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ABSTRACT
From February 26, 2020 to March 11, 2021, coronavirus disease 2019 (COVID-19) 
pandemic resulted in 11,439,558 cases and 277,102 deaths in Brazil. Among them, 2,195,130 
cases and 63,965 deaths occurred in Sao Paulo State, Southeast Brazil. The recent emergence 
and rise of new variants of SARS-CoV-2 is of concern because of their higher transmissibility 
and possible association with more severe disease. Cases of SARS-CoV-2 reinfections have 
been described since December 2020 in Brazil. This report describes two cases of COVID-19 
reinfection, that occurred five and six months after the first infection, during the second 
wave of the pandemic in Sao Paulo State. Both patients presented mild symptoms in the two 
COVID-19 episodes and different lineages of SARS-CoV-2 were identified: B.1.1.33 and 
B.1.1.28 lineages in case 1 and B1.1.128 and P. 2 lineages in case 2.
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INTRODUCTION
A total of 11,439,558 cases and 277,102 deaths were reported during COVID-19 
pandemic, from February 26, 2020 to March 11, 2021, in Brazil. Among them, 
2,195,130 cases and 63,965 deaths occurred in Sao Paulo State, Southeast Brazil. 
COVID-19 cases and deaths had increased again worldwide in November 2020, 
as well as in Sao Paulo State, that experienced a second wave with more reported 
cases and deaths than in the first wave1. 
Serious concerns about SARS-CoV-2 variants have grown during the COVID-19 
pandemic evolution. Globally, since the beginning of the pandemic, different 
SARS-CoV-2 variants have emerged and circulated and viral genomic sequencing 
and epidemiological investigations are necessary to monitor the emergence and 
circulation of these variants2,3. 
The USA Centers for Disease Control and Prevention (CDC) has recently 
developed a variant classification that defines three classes of SARS-CoV-2 variants: 
Variants of Interest, Variants of Concern and Variants of High Consequence. Variants 
of Interest are those associated with increased transmissibility and usually causing 
surges. Three variants are in this class: B.1.526 and B.1.525, both identified for the 
first time in the United States and P. 2, first detected in Brazil. Variants of Concern 
are those related with increased transmissibility and disease severity: B.1.1.7, first 
detected in the United Kingdom; P. 1, that has emerged in Brazil and has already 
been detected in several countries; B.1.351 from South Africa, as well as B.1.427 
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and B.1.429, both first detected in the United States. Variants 
of High Consequence cause increased disease severity and 
greater number of hospitalizations. Their identification 
requires notification to the World Health Organization 
(WHO) following the International Health Regulations. 
Currently, there are no SARS-CoV-2 variants described in 
this later class4.
Health care workers are at increased risk for SARS-
CoV-2 infections5. Frequently, they present with mild or 
moderate disease or are asymptomatic, although severe 
disease and death may occur in a smaller proportion 
of cases5-7. From February 26, 2020 to March 11, 741 
health care workers developed severe disease and needed 
hospitalization in Sao Paulo State, mostly physicians 
(31.9%) and nursing technicians (28.3%), according to the 
nationwide surveillance information system SIVEP-Gripe: 
Database8. 
The first SARS-CoV-2 reinfection was confirmed in 
Hong Kong in August 2020. Two samples from this patient 
underwent whole genome sequencing. Samples were 
collected 142 days apart and indicated that SARS-CoV-2 
viral genomes belonged to two different lineages. After this 
report, other similar events were recorded worldwide2,3. 
SARS-CoV-2 reinfection cases have been occurring in 
Brazil since December 2020, mainly in Rio Grande do 
Norte, Goias, Minas Gerais, Amazonas and Sao Paulo 
States1.
The Brazilian epidemiological surveillance adopted 
the same criteria of the CDC, defining a suspected case 
of COVID-19 reinfection as two SARS-CoV-2 infections 
detected by the real-time reverse transcription polymerase 
chain reaction (RT-PCR) assay, with an interval equal 
to or greater than 90 days, regardless of the presence of 
symptoms1. 
Whole viral genome sequencing was carried out by a 
Brazilian reference laboratory located at the Instituto Adolfo 
Lutz (IAL), through the Next Generation Sequencing 
(NGS) instrument Ion Torrent platform S5 (Thermo 
Fisher Scientific Inc., Waltham, MA, USA). The obtained 
strands were processed, evaluated and aligned by IRMA 
(Interative Refinement Meta-Assembler). The genetic 
material extracted from the two samples of both cases after 
RT-PCR using as target, the E gene (envelope protein), N 
(nucleocapsid protein) and RdRP (RNA – dependent RNA 
polymerase), in addition to duplicated endogenous human 
RNAse controls, which enabled the sequencing and the 
identification of two different lineages. Sequences were 
deposited by IAL at the Global Initiative on Sharing All 
Influenza Data – GISAID9.
This report describes two SARS-CoV-2 cases among 
health care workers of Sao Paulo State, with clinical and 
virological reinfections. Both episodes occurred during the 
second wave of the pandemic in Sao Paulo State. 
CASES REPORT
Case 1 was a 41-year-old woman with a gastroplasty 
history, who sought medical attention on 06/24/2020 
presenting with headache, myalgia, fatigue, fever, dry 
cough, shortness of breathe, anosmia and loss of taste, 
being classified as an influenza-like illness (ILI). The 
oropharynx swab RT-PCR for SARS-CoV-2 performed 
on 06/29/2020 resulted positive. As a nursing technician, 
she reported contact with COVID-19-positive cases. The 
symptoms lasted seven days. She sought medical attention 
twice after the first evaluation, and no abnormalities were 
observed in these two clinical evaluations. The patient 
remained asymptomatic until 11/17/2020 (146 days after 
the first episode), when she presented again with the same 
symptoms, by this time associated with diarrhea, loss of 
appetite and dizziness. The oropharynx swab RT-PCR for 
SARS-CoV-2 performed on 11/23/2020 resulted positive. 
The symptoms lasted about 20 days, without hospitalization, 
being classified again as an ILI. The whole SARS-CoV-2 
genome sequencing of the two samples revealed that the 
first infection, according to the Pangolin COVID-19 lineage 
assignment classification10, was caused by a B.1.1.33 
lineage (GISAID accession Nº EPI_ISL_708529), while 
the second one was caused by a B.1.1.28 lineage (GISAID 
accession Nº EPI_ISL_708530)11. The D614G spike protein 
mutation was found in both samples, from the two episodes, 
and the V1176F spike protein mutation was found in the 
sample from the second episode. The epidemiological, 
clinical and laboratory timeline of case 1 reinfection is 
depicted in Figure 1A.
Case 2, a 34-year-old woman, a nursing technician 
with a history of chronic respiratory disease, sought 
medical attention on 08/12/2020 presenting with fever, 
cough, odynophagia and dyspnea, being classified again 
as an ILI. The oropharynx swab RT-PCR for SARS-CoV-2 
collected on 08/17/2020 resulted positive. On 01/22/2021, 
the patient received the first dose of a COVID-19 
vaccine. On 02/01/2021, 173 days after the first episode 
and ten days after the vaccination, she presented with 
headache, running nose, fever and sore throat (ILI). The 
oropharynx swab RT-PCR for SARS- CoV-2 collected on 
02/04/2021, resulted positive. Whole genome sequencing 
revealed two different strains, according to the Pangolin 
lineage classification10: B.1.1.28 (GISAID accession 
Nº EPI_ISL_1121326) in the first episode and P. 2 (GISAID 
accession Nº EPI_ISL_1121321) in the second one. The 
D614G and V1176F spike protein mutations were found in 
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both samples from the two episodes in case 2 and the E484K 
spike protein mutation was found in the second episode 
only. Case 2 timeline is shown in Figure 1B.
DISCUSSION
Respiratory viruses’ high variability, different genotypes 
or species, a weak, incomplete or non-lasting immune 
response may explain the cases of reinfection, including 
the ones of coronaviruses2,3. This report describes two 
cases of symptomatic COVID-19 and positive RT-PCR five 
and six months after the first episode, during the second 
wave of the pandemic in Sao Paulo State, which started in 
November 2020.
Both patients presented with two episodes of infection 
and mild symptoms and they were classified as having ILI. 
Some studies have observed that mild COVID-19 symptoms 
may indicate a weak and non-lasting immune response to 
infection2,3.
COVID-19 reinfection was confirmed in both cases, 
since different phylogenetic profiles were identified in each 
event, 146 and 173 days apart, respectively. 
Case 1 presented with the B.1.1.33 lineage in the first 
episode and the B.1.1.28 lineage in the second one. Both 
strains were the main lineages that circulated throughout 
2020 in the Brazilian Southeast region, where Sao Paulo 
State is located12. Both lineages present with the D614G 
spike protein mutation that seems to be associated with 
higher viral load in patients and in animal models, and they 
are possibly able to infect younger patients more effectively, 
but it is not associated with more severe COVID-19 and 
increased mortality13,14. In the second episode, the detected 
lineage presented with the V1176F spike protein mutation 
whose role in COVID-19 remains to be established15.
There was a reduction in the identification of B.1.1.33 
lineage by the Southeast health surveillance system since 
September 2020, when the P. 2 lineage identified in the 
second episode in case 2, was beginning to circulate12. The 
P. 2 variant is classified by the CDC as a Variant of Interest, 
a sub-clade of B.1.1.28, which harbors the E484K spike 
protein mutation, associated with immune evasion from 
neutralizing antibodies. Reinfections associated with the 
P. 2 variant have been previously reported16,17. 
Health care workers are at increased risk for SARS-
CoV-2 infections in comparison with the general population 
due to the continued exposure to the virus at work. However, 
few studies evaluated other potential sources of infection, 
considering the pandemic dynamics and the impact of 
community-acquired infection5-7. 
The surveillance of emerging lineages are required 
and should lead to more epidemiological investigations to 
assess transmissibility, disease severity, risk of reinfection, 
improved laboratory characterization and impact on critical 
SARS-CoV-2 countermeasures, including vaccines4.
In conclusion, the identification, frequency and 
characterization of SARS-CoV-2 reinfection cases may 
contribute to the pandemic management and control.
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